Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
m2Cgh0sPjYL2q4et